Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Revenue

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹13,980 Cr₹11,516 Cr₹10,728 Cr₹9,620 Cr₹8,508 Cr

What is the latest Revenue of TORRENT PHARMACEUTICALS ?

The latest Revenue ratio of TORRENT PHARMACEUTICALS is ₹13,980 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹13,980 Cr
Mar2025₹11,516 Cr
Mar2024₹10,728 Cr
Mar2023₹9,620 Cr
Mar2022₹8,508 Cr

How is Revenue of TORRENT PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹13,980 Cr
21.39
Mar2025 ₹11,516 Cr
7.35
Mar2024 ₹10,728 Cr
11.51
Mar2023 ₹9,620 Cr
13.07
Mar2022 ₹8,508 Cr -

Compare Revenue of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹177,348.2 Cr -2.3% 1.5% 23.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,291.0 Cr -1.8% 7.6% 11.2% Stock Analytics
DIVIS LABORATORIES ₹305,014.0 Cr 3.7% 27.2% 71.1% Stock Analytics
DR REDDYS LABORATORIES ₹115,017.0 Cr 0.6% 13.4% 15.7% Stock Analytics
CIPLA ₹112,539.0 Cr -1.3% 6.1% -6.9% Stock Analytics
MANKIND PHARMA ₹109,622.0 Cr 3% 13.9% 17.8% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-2.3%

1.5%

23.6%

SENSEX

0.7%

11.7%

-2%


You may also like the below Video Courses